{"id":16732,"date":"2026-06-25T01:12:04","date_gmt":"2026-06-25T01:12:04","guid":{"rendered":"https:\/\/tractus.jp\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\/"},"modified":"2026-06-25T22:39:34","modified_gmt":"2026-06-25T22:39:34","slug":"tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition","status":"publish","type":"post","link":"https:\/\/tractus.jp\/en\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\/","title":{"rendered":"Tractus M&#038;A Partners Advises Rohto Pharmaceutical on Successful Closing of THANN Oryza Acquisition"},"content":{"rendered":"\n<p><strong>[Bangkok, Thailand, <em>29 May 2026<\/em>]<\/strong> \u2013 Tractus, through its corporate finance arm, <a href=\"https:\/\/e.ate.wpml.org\/dashboard?id=200769691&amp;language=en#:~:text=TRACTUS%20M&amp;A-,PARTNERS,-(Alt%20+%203\">TRACTUS M&amp;A PARTNERS<\/a>, today announced the successful completion of its engagement as exclusive financial advisor to <a href=\"https:\/\/www.rohto.co.jp\/global\/\">ROHTO PHARMACEUTICAL Co., Ltd<\/a>. (Code: 4527) on its acquisition of a 51% stake in <a href=\"http:\/\/www.thann.info\/\">THANN Oryza Co., Ltd<\/a>. (\u201cTHANN\u201d), one of Thailand\u2019s most recognized natural skincare and wellness brands.<\/p>\n\n<p>The transaction has now closed, following the <a href=\"https:\/\/tractus-asia.com\/press-release\/tractus-advises-rohto-pharmaceutical-thann-acquisition\/\">SIGNING OF THE SHARE PURCHASE AGREEMENT<\/a> in Osaka, Japan on 7 January 2026. Rohto engaged Tractus M&amp;A Partners to identify and evaluate acquisition opportunities in Thailand aligned with its product portfolio and growth strategy. Drawing on its deep, on-the-ground knowledge of the Thai market, Tractus conducted a rigorous screening of more than 500 companies across the country\u2019s healthcare, pharmaceutical, cosmetics, and wellness industries before identifying THANN as the ideal partner on the basis of financial strength, complementary product portfolios, and cultural alignment.<\/p>\n\n<p>After reaching a mutual agreement, Tractus M&amp;A Partners coordinated the valuation, due diligence, negotiations, structuring of the transaction, and preparation of closing documents, leading the transaction management process from start to finish and successfully completing the acquisition of shares in Bangkok, Thailand. This transaction marks another milestone in Tractus\u2019s track record of guiding international acquirers through complex cross-border transactions in Thailand and throughout Asia.<\/p>\n\n<p>\u201cThis transaction reflects the kind of cross-border value we are built to create,\u201d said John Evans, Managing Director at Tractus. \u201cOur role was to align Rohto\u2019s strategy with the right target and then steer the deal to a successful close through rigorous financial analysis and genuine cultural fluency. We are proud to have guided this transaction from initial screening to completion.\u201d<\/p>\n\n<p>The partnership sees THANN join the Rohto-Mentholatum portfolio, bringing more than 160 natural botanical skin and hair care products that combine traditional natural healing methods with modern skincare science. THANN products are currently available through over 70 retail locations and The partnership with Rohto-Mentholatum will see THANN\u2019s presence deepen in existing markets, expand into new ones, and continue to develop products that define modern wellness.<\/p>\n\n<p>Rohto\u2019s EVP &amp; CFO, Mr. Masaya Saito, remarked: \u201cI am pleased to announce the successful completion of Rohto Pharmaceutical\u2019s acquisition of a 51% stake in THANN. While closing marks the conclusion of the transaction, it is also the beginning of a long-term partnership, one through which we will integrate THANN\u2019s products into the Rohto-Mentholatum portfolio and expand the brand across Asia and around the world. We are delighted to embark on this journey alongside THANN and its founder, Mr. Thitipat Suppattranont, and we look forward to creating lasting value together.\u201d<\/p>\n\n<p>Under the terms of the transaction, Rohto will nominate three directors to THANN to work alongside Mr. Thitipat Suppattranont, THANN\u2019s Founder and Managing Director, in shaping its future strategy. Financial terms of the transaction were not disclosed.<\/p>\n\n<p>\u201cI am excited by the opportunities we will create through this partnership,\u201d said Mr. Thitipat Suppattranont. \u201cFrom our earliest discussions, I knew Rohto was the ideal partner for entering into a joint-venture partnership to continue THANN\u2019s growth across Asia and globally.\u201d<\/p>\n\n<p><strong>Advisors<\/strong><br\/>Tractus M&amp;A Partners acted as exclusive financial advisor to Rohto Pharmaceutical on the transaction. <a href=\"https:\/\/www.kap.co.th\/\">KUDUN AND PARTNERS<\/a> Legal counsel to Rohto, Kriengsak Lao-Arpasuwong Advisor to THANN, and <a href=\"https:\/\/www.bdo.th\/en-gb\/home\">BDO<\/a> Tax and Financial due-diligence advisors also supported the parties.<\/p>\n\n<p><strong>Tractus Deal Team<\/strong><br\/><a href=\"https:\/\/tractus-asia.com\/leadership\/john-evans\/\" target=\"_blank\" rel=\"noreferrer noopener\">JOHN EVANS<\/a>, Founder and Managing Director<br\/><a href=\"https:\/\/tractus-asia.com\/leadership\/shinichiro-kawazoe\/\" target=\"_blank\" rel=\"noreferrer noopener\">SHINICHIRO KAWAZOE<\/a>, Chief Representative Tractus Japan<br\/><a href=\"https:\/\/tractus-asia.com\/leadership\/james-meisenheimer\/\" target=\"_blank\" rel=\"noreferrer noopener\">JAMES MEISENHEIMER<\/a>, Consulting Manager (Thailand)<br\/>Yada Saraneeyatham, Consultant (Thailand)<br\/>Pei Wen Ng, Consultant (Singapore)<\/p>\n\n<p>About Tractus<br\/>Tractus is a Pan-Asian business advisory firm that helps companies enter, operate, and grow across the region. With 30+ years of experience and 15 offices across Asia and the U.S., the firm works across site selection, market entry, corporate finance and economic development. Through its corporate finance arm, Tractus M&amp;A Partners, it provides buy-side and sell-side advisory, target identification, end-to-end transaction management, and post-merger integration support for clients pursuing cross-border growth in Asia.<\/p>\n\n<p><strong>For media inquiries or further information, please contact:<\/strong><br\/>Sarah Gorecki<br\/>Marketing Coordinator<br\/><a href=\"mailto:SARAH.GORECKI@TRACTUS-ASIA.COM\">SARAH.GORECKI@TRACTUS-ASIA.COM<\/a><\/p>\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>[Bangkok, Thailand, 29 May 2026] \u2013 Tractus, through its corporate finance arm, TRACTUS M&amp;A PARTNERS, today announced the successful completion of its engagement as exclusive financial advisor to ROHTO PHARMACEUTICAL Co., Ltd. (Code: 4527) on its acquisition of a 51% stake in THANN Oryza Co., Ltd. (\u201cTHANN\u201d), one of Thailand\u2019s most recognized natural skincare and [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":16712,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[53,79],"tags":[],"class_list":["post-16732","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-insights","category-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tractus M&amp;A Partners Advises Rohto Pharmaceutical on Successful Closing of THANN Oryza Acquisition - Tractus Japan<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tractus.jp\/en\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tractus M&amp;A Partners Advises Rohto Pharmaceutical on Successful Closing of THANN Oryza Acquisition - Tractus Japan\" \/>\n<meta property=\"og:description\" content=\"[Bangkok, Thailand, 29 May 2026] \u2013 Tractus, through its corporate finance arm, TRACTUS M&amp;A PARTNERS, today announced the successful completion of its engagement as exclusive financial advisor to ROHTO PHARMACEUTICAL Co., Ltd. (Code: 4527) on its acquisition of a 51% stake in THANN Oryza Co., Ltd. (\u201cTHANN\u201d), one of Thailand\u2019s most recognized natural skincare and [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tractus.jp\/en\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\/\" \/>\n<meta property=\"og:site_name\" content=\"Tractus Japan\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-25T01:12:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-25T22:39:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tractus.jp\/wp-content\/uploads\/2026\/06\/272351.jpg-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1477\" \/>\n\t<meta property=\"og:image:height\" content=\"1108\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Kimihiro Iwao\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kimihiro Iwao\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/tractus.jp\\\/en\\\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/tractus.jp\\\/en\\\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\\\/\"},\"author\":{\"name\":\"Kimihiro Iwao\",\"@id\":\"https:\\\/\\\/tractus.jp\\\/en\\\/#\\\/schema\\\/person\\\/eab6209c011285b4aa4e62d64b1201b9\"},\"headline\":\"Tractus M&#038;A Partners Advises Rohto Pharmaceutical on Successful Closing of THANN Oryza Acquisition\",\"datePublished\":\"2026-06-25T01:12:04+00:00\",\"dateModified\":\"2026-06-25T22:39:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/tractus.jp\\\/en\\\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\\\/\"},\"wordCount\":682,\"publisher\":{\"@id\":\"https:\\\/\\\/tractus.jp\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/tractus.jp\\\/en\\\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/tractus.jp\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/272351.jpg-1.webp\",\"articleSection\":[\"Insights\",\"Press Release\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/tractus.jp\\\/en\\\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\\\/\",\"url\":\"https:\\\/\\\/tractus.jp\\\/en\\\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\\\/\",\"name\":\"Tractus M&A Partners Advises Rohto Pharmaceutical on Successful Closing of THANN Oryza Acquisition - Tractus Japan\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/tractus.jp\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/tractus.jp\\\/en\\\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/tractus.jp\\\/en\\\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/tractus.jp\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/272351.jpg-1.webp\",\"datePublished\":\"2026-06-25T01:12:04+00:00\",\"dateModified\":\"2026-06-25T22:39:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/tractus.jp\\\/en\\\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/tractus.jp\\\/en\\\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/tractus.jp\\\/en\\\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\\\/#primaryimage\",\"url\":\"https:\\\/\\\/tractus.jp\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/272351.jpg-1.webp\",\"contentUrl\":\"https:\\\/\\\/tractus.jp\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/272351.jpg-1.webp\",\"width\":1477,\"height\":1108},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/tractus.jp\\\/en\\\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/tractus.jp\\\/en\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tractus M&#038;A Partners Advises Rohto Pharmaceutical on Successful Closing of THANN Oryza Acquisition\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/tractus.jp\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/tractus.jp\\\/en\\\/\",\"name\":\"Tractus Japan\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/tractus.jp\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/tractus.jp\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/tractus.jp\\\/en\\\/#organization\",\"name\":\"Tractus Japan\",\"url\":\"https:\\\/\\\/tractus.jp\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/tractus.jp\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/tractus.jp\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Logo-r4-final_standard.png-1024x277-1.png\",\"contentUrl\":\"https:\\\/\\\/tractus.jp\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Logo-r4-final_standard.png-1024x277-1.png\",\"width\":1024,\"height\":277,\"caption\":\"Tractus Japan\"},\"image\":{\"@id\":\"https:\\\/\\\/tractus.jp\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/tractus.jp\\\/en\\\/#\\\/schema\\\/person\\\/eab6209c011285b4aa4e62d64b1201b9\",\"name\":\"Kimihiro Iwao\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3a146ea32f5021b35b56bd39399441e02cc15834b3e8f0c42ce10f47533abe3c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3a146ea32f5021b35b56bd39399441e02cc15834b3e8f0c42ce10f47533abe3c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3a146ea32f5021b35b56bd39399441e02cc15834b3e8f0c42ce10f47533abe3c?s=96&d=mm&r=g\",\"caption\":\"Kimihiro Iwao\"},\"url\":\"https:\\\/\\\/tractus.jp\\\/en\\\/author\\\/roitractus\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tractus M&A Partners Advises Rohto Pharmaceutical on Successful Closing of THANN Oryza Acquisition - Tractus Japan","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tractus.jp\/en\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\/","og_locale":"en_US","og_type":"article","og_title":"Tractus M&A Partners Advises Rohto Pharmaceutical on Successful Closing of THANN Oryza Acquisition - Tractus Japan","og_description":"[Bangkok, Thailand, 29 May 2026] \u2013 Tractus, through its corporate finance arm, TRACTUS M&amp;A PARTNERS, today announced the successful completion of its engagement as exclusive financial advisor to ROHTO PHARMACEUTICAL Co., Ltd. (Code: 4527) on its acquisition of a 51% stake in THANN Oryza Co., Ltd. (\u201cTHANN\u201d), one of Thailand\u2019s most recognized natural skincare and [&hellip;]","og_url":"https:\/\/tractus.jp\/en\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\/","og_site_name":"Tractus Japan","article_published_time":"2026-06-25T01:12:04+00:00","article_modified_time":"2026-06-25T22:39:34+00:00","og_image":[{"width":1477,"height":1108,"url":"https:\/\/tractus.jp\/wp-content\/uploads\/2026\/06\/272351.jpg-1.webp","type":"image\/webp"}],"author":"Kimihiro Iwao","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Kimihiro Iwao","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/tractus.jp\/en\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\/#article","isPartOf":{"@id":"https:\/\/tractus.jp\/en\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\/"},"author":{"name":"Kimihiro Iwao","@id":"https:\/\/tractus.jp\/en\/#\/schema\/person\/eab6209c011285b4aa4e62d64b1201b9"},"headline":"Tractus M&#038;A Partners Advises Rohto Pharmaceutical on Successful Closing of THANN Oryza Acquisition","datePublished":"2026-06-25T01:12:04+00:00","dateModified":"2026-06-25T22:39:34+00:00","mainEntityOfPage":{"@id":"https:\/\/tractus.jp\/en\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\/"},"wordCount":682,"publisher":{"@id":"https:\/\/tractus.jp\/en\/#organization"},"image":{"@id":"https:\/\/tractus.jp\/en\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\/#primaryimage"},"thumbnailUrl":"https:\/\/tractus.jp\/wp-content\/uploads\/2026\/06\/272351.jpg-1.webp","articleSection":["Insights","Press Release"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/tractus.jp\/en\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\/","url":"https:\/\/tractus.jp\/en\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\/","name":"Tractus M&A Partners Advises Rohto Pharmaceutical on Successful Closing of THANN Oryza Acquisition - Tractus Japan","isPartOf":{"@id":"https:\/\/tractus.jp\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tractus.jp\/en\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\/#primaryimage"},"image":{"@id":"https:\/\/tractus.jp\/en\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\/#primaryimage"},"thumbnailUrl":"https:\/\/tractus.jp\/wp-content\/uploads\/2026\/06\/272351.jpg-1.webp","datePublished":"2026-06-25T01:12:04+00:00","dateModified":"2026-06-25T22:39:34+00:00","breadcrumb":{"@id":"https:\/\/tractus.jp\/en\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tractus.jp\/en\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tractus.jp\/en\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\/#primaryimage","url":"https:\/\/tractus.jp\/wp-content\/uploads\/2026\/06\/272351.jpg-1.webp","contentUrl":"https:\/\/tractus.jp\/wp-content\/uploads\/2026\/06\/272351.jpg-1.webp","width":1477,"height":1108},{"@type":"BreadcrumbList","@id":"https:\/\/tractus.jp\/en\/tractus-ma-partners-advises-rohto-pharmaceutical-on-successful-closing-of-thann-oryza-acquisition\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tractus.jp\/en\/home\/"},{"@type":"ListItem","position":2,"name":"Tractus M&#038;A Partners Advises Rohto Pharmaceutical on Successful Closing of THANN Oryza Acquisition"}]},{"@type":"WebSite","@id":"https:\/\/tractus.jp\/en\/#website","url":"https:\/\/tractus.jp\/en\/","name":"Tractus Japan","description":"","publisher":{"@id":"https:\/\/tractus.jp\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tractus.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/tractus.jp\/en\/#organization","name":"Tractus Japan","url":"https:\/\/tractus.jp\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tractus.jp\/en\/#\/schema\/logo\/image\/","url":"https:\/\/tractus.jp\/wp-content\/uploads\/2026\/03\/Logo-r4-final_standard.png-1024x277-1.png","contentUrl":"https:\/\/tractus.jp\/wp-content\/uploads\/2026\/03\/Logo-r4-final_standard.png-1024x277-1.png","width":1024,"height":277,"caption":"Tractus Japan"},"image":{"@id":"https:\/\/tractus.jp\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/tractus.jp\/en\/#\/schema\/person\/eab6209c011285b4aa4e62d64b1201b9","name":"Kimihiro Iwao","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/3a146ea32f5021b35b56bd39399441e02cc15834b3e8f0c42ce10f47533abe3c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3a146ea32f5021b35b56bd39399441e02cc15834b3e8f0c42ce10f47533abe3c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3a146ea32f5021b35b56bd39399441e02cc15834b3e8f0c42ce10f47533abe3c?s=96&d=mm&r=g","caption":"Kimihiro Iwao"},"url":"https:\/\/tractus.jp\/en\/author\/roitractus\/"}]}},"_links":{"self":[{"href":"https:\/\/tractus.jp\/en\/wp-json\/wp\/v2\/posts\/16732","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tractus.jp\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tractus.jp\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tractus.jp\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/tractus.jp\/en\/wp-json\/wp\/v2\/comments?post=16732"}],"version-history":[{"count":1,"href":"https:\/\/tractus.jp\/en\/wp-json\/wp\/v2\/posts\/16732\/revisions"}],"predecessor-version":[{"id":16733,"href":"https:\/\/tractus.jp\/en\/wp-json\/wp\/v2\/posts\/16732\/revisions\/16733"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tractus.jp\/en\/wp-json\/wp\/v2\/media\/16712"}],"wp:attachment":[{"href":"https:\/\/tractus.jp\/en\/wp-json\/wp\/v2\/media?parent=16732"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tractus.jp\/en\/wp-json\/wp\/v2\/categories?post=16732"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tractus.jp\/en\/wp-json\/wp\/v2\/tags?post=16732"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}